Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 2/20 | 0.62 |
| ▸ | ITGB3 | P05106 | 1/20 | 0.62 |
| ▸ | ITGA2B | P08514 | 1/20 | 0.62 |
| ▸ | GAA | P10253 | 1/20 | 0.62 |
| ▸ | MAPT | P10636 | 2/20 | 0.62 |
| ▸ | SLC13A5 | Q86YT5 | 1/20 | 0.62 |
| ▸ | FKBP1A | P62942 | 3/20 | 0.54 |
| ▸ | GSK3B | P49841 | 1/20 | 0.51 |
| ▸ | FFAR1 | O14842 | 2/20 | 0.50 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.50 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.49 |
| ▸ | KEAP1 | Q14145 | 1/20 | 0.48 |
| ▸ | ME2 | P23368 | 1/20 | 0.48 |
| ▸ | ME1 | P48163 | 1/20 | 0.48 |
| ▸ | ME3 | Q16798 | 1/20 | 0.48 |
| ▸ | PPARD | Q03181 | 1/20 | 0.48 |
| ▸ | PPARA | Q07869 | 1/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27989630 | 0.88 | MAPT (0.59) | LMNAITGB3ITGA2BGAAMAPT | |
| SCHEMBL10695749 | 0.86 | ITGB3 (0.66) | LMNAITGB3ITGA2BGAAMAPT | |
| SCHEMBL2330058 | 0.85 | MAPT (0.57) | LMNAITGB3ITGA2BGAAMAPT | |
| SCHEMBL847349 | 0.85 | ITGB3 (0.64) | LMNAITGB3ITGA2BGAAMAPT | |
| SCHEMBL30151165 | 0.83 | KMO (0.58) | LMNAITGB3ITGA2BGAAMAPT | |
| SCHEMBL2649726 | 0.83 | ITGB3 (0.60) | LMNAITGB3ITGA2BMAPTSLC13A5 | |
| Hydrochloric Acid SCHEMBL31627554 | 0.83 | KMT2A (0.60) | LMNAITGB3ITGA2BGAAMAPT | |
| SCHEMBL28299497 | 0.83 | MAPT (0.55) | LMNAITGB3ITGA2BGAAMAPT | |
| SCHEMBL27777322 | 0.83 | MAPT (0.58) | LMNAITGB3ITGA2BGAAMAPT | |
| SCHEMBL2302994 | 0.82 | ITGB3 (0.61) | LMNAITGB3ITGA2BGAAMAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12018048-B2 | Anthelmintic depsipeptide compounds | Boehringer Ingelheim Animal Health USA Inc. (US) | 2024-06-25 | — | — | US | disclosed |
| CN-114057668-B | Synthesis method of amino protecting group chiral 2-amino-3- (4-morpholinylphenyl) propionic acid | 马鞍山诺恩特医药科技有限公司 | 2023-08-25 | — | — | CN | disclosed |
| CN-114891070-A | Anthelmintic depsipeptide compounds | 勃林格殷格翰动物保健美国公司 | 2022-08-12 | — | — | CN | disclosed |
| CN-107835818-B | Anthelmintic depsipeptide compounds | 勃林格殷格翰动物保健美国公司 | 2022-04-29 | — | — | CN | disclosed |
| US-20220098241-A1 | ANTHELMINTIC DEPSIPEPTIDE COMPOUNDS | Boehringer Ingelheim Animal Health USA Inc. (US) | 2022-03-31 | — | — | US | disclosed |
| CN-114057668-A | Synthesis method of amino protecting group chiral 2-amino-3- (4-morpholinylphenyl) propionic acid | 马鞍山诺恩特医药科技有限公司 | 2022-02-18 | — | — | CN | disclosed |
| EP-0718293-B1 | CYCLODEPSIPEPTIDE COMPOUND | FUJISAWA PHARMACEUTICAL CO (JP) | 2002-03-13 | — | — | EP | disclosed |
| EP-0718293-A1 | CYCLODEPSIPEPTIDE COMPOUND | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 1996-06-26 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12018048-B2 | Anthelmintic depsipeptide compounds | VIP, DNPEP, DPEP1 | LMNA 2297/4885ITGB3 4634/4885ITGA2B 4708/4885 |
| US-20220098241-A1 | ANTHELMINTIC DEPSIPEPTIDE COMPOUNDS | VIP, PREP, DNPEP | LMNA 2969/4885ITGB3 4674/4885ITGA2B 4763/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.